List of insiders holdings for Vanda Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Polymeropoulos Mihael Hristos President and CEO | 2024-03-06 16:47:54 | 1,871,730 0 | 1,871,730 | Form 4 |
RHO VENTURES IV LP RHO VENTURES IV QP LP RHO VENTURES IV GMBH & CO BETEILIGUNGS KG RHO CAPITAL PARTNERS VERWALTUNGS GMBH RHO MANAGEMENT VENTURES IV LLC RHO CAPITAL PARTNERS INC RUCH JOSHUA KAIROUZ HABIB LESCHLY MARK RHO MANAGEMENT TRUST I 10% Owner | 2006-11-17 17:04:38 | 0 1,862,692 | 1,862,692 | Form 4 |
Biomedical Sciences Investment Fund Pte Ltd. Bio One Capital Pte Ltd. EDB Investments Pte Ltd. 10% Owner | 2006-12-01 17:10:25 | 0 1,856,957 | 1,856,957 | Form 4 |
HOCKMEYER WAYNE T Director | 2006-04-18 15:42:44 | 0 1,601,798 | 1,601,798 | Form 4 |
MEDIMMUNE INC 10% Owner | 2006-04-18 15:50:07 | 1,601,798 0 | 1,601,798 | Form 4 |
PROSPECT VENTURE PARTNERS II LP PROSPECT ASSOCIATES II L P PROSPECT MANAGEMENT CO II LLC SCHNELL DAVID BARKAS ALEXANDER E HIRSCH RUSSELL C 10% Owner | 2006-11-07 17:46:17 | 0 943,372 | 943,372 | Form 4 |
MORE ROBERT J 10% Owner | 2006-12-13 16:39:45 | 0 612,027 | 612,027 | Form 4 |
VITULLO NICOLE 10% Owner | 2006-12-13 16:41:51 | 0 612,027 | 612,027 | Form 4 |
SCHOEMAKER KATHLEEN K 10% Owner | 2006-12-13 16:36:43 | 0 612,027 | 612,027 | Form 4 |
TREU JESSE I 10% Owner | 2006-12-13 16:33:30 | 0 612,027 | 612,027 | Form 4 |
DOVEY BRIAN H 10% Owner | 2006-12-13 16:31:03 | 0 612,027 | 612,027 | Form 4 |
BLAIR JAMES C 10% Owner | 2006-12-13 16:28:05 | 0 612,027 | 612,027 | Form 4 |
Repella Robert SVP & Chief Commercial Officer | 2013-11-21 20:02:30 | 392,610 0 | 392,610 | Form 4 |
Birznieks Gunther SVP, Business Development | 2024-03-06 16:46:00 | 313,569 0 | 313,569 | Form 4 |
Gibbs Thomas Edward SVP, Chief Commercial Officer | 2015-04-21 16:21:52 | 235,000 0 | 235,000 | Form 4 |
Moran Kevin Patrick SVP, CFO & Treasurer | 2024-07-29 17:24:41 | 228,763 635 | 229,398 | Form 4 |
Williams Timothy SVP & General Counsel | 2024-03-06 16:50:29 | 196,825 0 | 196,825 | Form 4 |
Kelly James Patrick EVP & Chief Financial Officer | 2020-03-04 17:01:37 | 186,869 0 | 186,869 | Form 4 |
Gulino Richard L. SVP, General Counsel & Sec. | 2018-03-02 17:33:30 | 185,073 0 | 185,073 | Form 4 |
Clark William D Sr. VP, Chief Business Officer | 2010-02-23 10:05:55 | 168,279 0 | 168,279 | Form 4 |
Reverberi Gian Piero SVP & Chief Commercial Officer | 2020-03-04 17:02:59 | 165,384 0 | 165,384 | Form 4 |
Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-17 08:52:04 | 162,362 0 | 162,362 | Form 4 |
DUGAN RICHARD W Director | 2024-05-21 16:53:30 | 155,807 0 | 155,807 | Form 4 |
Wijkstrom Joakim SVP, Chief Marketing Officer | 2024-03-06 16:48:50 | 129,789 0 | 129,789 | Form 4 |
CARE CAPITAL II LLC CARE CAPITAL INVESTMENTS II LP Care Capital Offshore Investments II LP LESCHLY JAN 10% Owner | 2006-12-14 16:18:40 | 0 121,546 | 121,546 | Form 4 |
SHALLCROSS STEVEN A Sr. VP, CFO, Treasurer | 2008-01-08 16:35:17 | 120,000 0 | 120,000 | Form 4 |
Chrousos Phaedra Director | 2024-05-24 16:43:11 | 104,327 0 | 104,327 | Form 4 |
Honore Tage Director | 2024-05-21 16:55:09 | 101,822 0 | 101,822 | Form 4 |
Gianchetti Albert W. Sr.VP,Chief Commercial Officer | 2008-01-08 16:31:26 | 100,000 0 | 100,000 | Form 4 |
Ward Anne Sempowski Director | 2024-05-21 16:52:54 | 97,420 0 | 97,420 | Form 4 |
Baroldi Paolo SVP & Chief Medical Officer | 2017-01-05 17:13:21 | 91,865 0 | 91,865 | Form 4 |
Watkins Thomas Director | 2022-06-03 16:31:07 | 63,064 0 | 63,064 | Form 4 |
Mitchell Stephen Ray Director | 2024-11-18 17:45:50 | 44,857 0 | 44,857 | Form 4 |
Copmann Thomas Lyle VP of Regulatory Affairs | 2006-04-12 13:54:46 | 35,349 0 | 35,349 | Form 3 |
COLA MICHAEL F Director | 2019-06-17 17:02:14 | 25,000 0 | 25,000 | Form 4 |
DP VI Associates L.P. 10% Owner | 2006-12-13 16:25:31 | 21,068 0 | 21,068 | Form 4 |
MILANO VINCENT Director | 2018-06-15 16:30:40 | 20,000 0 | 20,000 | Form 4 |
PIEN HOWARD H Director | 2015-06-22 18:21:02 | 15,000 0 | 15,000 | Form 4 |
Galson Steven K Director | 2014-05-27 17:41:21 | 15,000 0 | 15,000 | Form 4 |
TANANBAUM JAMES B Director | 2007-05-18 15:59:32 | 15,000 0 | 15,000 | Form 4 |
KARABELAS ARGERIS N Director | 2011-06-17 17:14:39 | 15,000 0 | 15,000 | Form 4 |
BATE KENNETH Director | 2017-06-19 21:58:20 | 15,000 0 | 15,000 | Form 4 |
Halak Brian K Director | 2010-03-30 11:03:01 | 14,552 0 | 14,552 | Form 4 |
Feeney John Joseph SVP & Chief Medical Officer | 2012-07-20 17:04:14 | 11,942 0 | 11,942 | Form 4/A |
Phadke Deepak Shripad Vice President Manufacturing | 2006-12-13 15:36:36 | 10,386 0 | 10,386 | Form 4 |
Irish Stephanie Rast Acting CFO/Treasurer | 2010-02-23 10:04:54 | 2,249 0 | 2,249 | Form 4 |
Ramsay David Russ Former Director Director | 2010-03-15 13:27:35 | 0 0 | 0 | Form 4 |
TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 2014-01-16 09:15:09 | 0 0 | 0 | Form 13G |
Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. DEERFIELD PARTNERS LP Deerfield International Master Fund L.P. Possible Member of 10% Group 10% Owner | 2018-02-14 09:00:36 | 0 0 | 0 | Form 13G |
Domain Partners VI L.P. 10% Owner | 2010-01-21 12:12:01 | 0 0 | 0 | Form 13G |
Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield International Master Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Special Situations Fund L.P. Possible Member of 10% Group 10% Owner | 2018-02-14 09:00:36 | 0 0 | 0 | Form 13G |